Cover Image
Market Research Report

Global Sleep Apnea Diagnostic and Therapeutic Market Forecast 2019-2027

Published by Inkwood Research Product code 802173
Published Content info 122 Pages
Delivery time: 2-3 business days
Price
Back to Top
Global Sleep Apnea Diagnostic and Therapeutic Market Forecast 2019-2027
Published: March 9, 2019 Content info: 122 Pages
Description

KEY FINDINGS

The disorder of sleep apnea occurs when a patient's breathing patterns during sleep decreases or pauses momentarily (called apnea) for 10 seconds or longer and it can occur 30 times or more in an hour.

The global sleep apnea diagnostic and therapeutic market is anticipated to generate revenue of $9,986 million by 2027 and will grow at an estimated CAGR of 6.72% between 2019 and 2027. Increase in the number of shift workers, the rising prevalence of sleep apnea and the technological advancements are mainly driving the market growth.

MARKET INSIGHTS

Obesity is considered a major risk factor in the development and progression of sleep apnea. The prevalence of sleep apnea in obese patients is almost two-fold higher than the normal case. Some of the factors that are expected to contribute to the sleeping disorders in the elderly population are retirements, various cognitive problems, excessive daytime sleepiness, and many more.

The medical devices are specialized equipment that requires government approval for their sale. Obtaining approval can be a time-consuming and high-cost procedure, which can affect market growth. The need for R&D efforts and low heat resistance are the major factors hindering the sleep apnea diagnostic and therapeutic market.

REGIONAL INSIGHTS

Geographically, the global sleep apnea diagnostic and therapeutic market has been segmented on the basis of four major regions, i.e., North America, Europe, Asia Pacific and the remaining countries forming the Rest of World regional segment.

The North America sleep apnea diagnostic and therapeutic market is expected to hold the largest share by 2027 because of the rise in number of incidences of sleep apnea and lack of patient awareness regarding the disease and also the presence of sophisticated healthcare infrastructure coupled with high healthcare expenditures and patient disposable incomes.

COMPETITIVE INSIGHTS

The major market players operating in the market are CareFusion (Merged With Becton Dickinson), Koninklijke Philips N.V. (Philips), Resmed Inc., Nihon Kohden Corporation, Medtronic PLC, Smiths Group PLC (Smiths Medical), Itamar Medical Ltd., Invacare Corp., Fisher & Paykel Healthcare, Drive Devilbiss Healthcare, Cadwell, GE Healthcare, Teleflex, Braebon Medical Corporation and Somnomedics. These market players follow several key developmental strategies and focus on launching innovative diagnosis products to cater to patient's as well as medical professional's requirements and to strengthen their market share.

Table of Contents
Product Code: 24143

Table of Contents

1. RESEARCH SCOPE

  • 1.1. STUDY GOALS
  • 1.2. SCOPE OF THE MARKET STUDY
  • 1.3. WHO WILL FIND THIS REPORT USEFUL?
  • 1.4. STUDY AND FORECASTING YEARS

2. RESEARCH METHODOLOGY

  • 2.1. SOURCES OF DATA
    • 2.1.1. SECONDARY DATA
    • 2.1.2. PRIMARY DATA
  • 2.2. TOP-DOWN APPROACH
  • 2.3. BOTTOM-UP APPROACH
  • 2.4. DATA TRIANGULATION

3. EXECUTIVE SUMMARY

  • 3.1. MARKET SUMMARY
  • 3.2. KEY FINDINGS
    • 3.2.1. POLYSOMNOGRAPHY DEVICE (PSG) HOLDS THE LARGEST MARKET SHARE IN TERMS OF DIAGNOSTIC MARKET
    • 3.2.2. HOSPITAL & SLEEP LAB DOMINATED THE GLOBAL SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET
    • 3.2.3. ORAL APPLIANCES ARE THE FASTEST GROWING THERAPEUTIC

4. MARKET DETERMINANTS

  • 4.1. MARKET SCOPE & DEFINITION
  • 4.2. MARKET DRIVERS
    • 4.2.1. INCREASE IN THE INCIDENCE OF OBESITY
    • 4.2.2. INCREASING GERIATRIC POPULATION
    • 4.2.3. INCREASE IN NUMBER OF SHIFT WORKERS
    • 4.2.4. RISING PREVALENCE OF SLEEP APNEA
    • 4.2.5. TECHNOLOGICAL ADVANCEMENTS
  • 4.3. MARKET RESTRAINTS
    • 4.3.1. HIGH COST OF SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC DEVICES
    • 4.3.2. LACK OF AWARENESS OF THE SLEEP APNEA DISORDER
  • 4.4. MARKET OPPORTUNITIES
    • 4.4.1. LUCRATIVE OPPORTUNITIES IN DEVELOPING ECONOMIES
    • 4.4.2. INCREASE IN THE DEVELOPMENT OF SLEEP MEDICATION TO REDUCE SIDE EFFECTS
    • 4.4.3. GROWING OCCURRENCE OF SLEEP APNEA IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
  • 4.5. MARKET CHALLENGES
    • 4.5.1. PATENT EXPIRATIONS
    • 4.5.2. DEARTH OF PATIENT COMPLIANCE

5. MARKET BY DIAGNOSTIC AND THERAPEUTIC

  • 5.1. DIAGNOSTIC
    • 5.1.1. POLYSOMNOGRAPHY DEVICE (PSG)
      • 5.1.1.1. CLINICAL PSG DEVICE
      • 5.1.1.2. AMBULATORY PSG DEVICE
    • 5.1.2. SLEEP APNEA SCREENING DEVICE
    • 5.1.3. ACTIGRAPHY MONITORING DEVICE
    • 5.1.4. RESPIRATORY POLYGRAPH
    • 5.1.5. OXIMETER
      • 5.1.5.1. FINGERTIP OXIMETER
      • 5.1.5.2. HANDHELD OXIMETER
      • 5.1.5.3. WRIST-WORN OXIMETER
      • 5.1.5.4. TABLETOP OXIMETER
  • 5.2. THERAPEUTIC
    • 5.2.1. AIRWAY CLEARANCE SYSTEMS
    • 5.2.2. ADAPTIVE SERVO-VENTILATION SYSTEMS
    • 5.2.3. POSITIVE AIRWAY PRESSURE (PAP) DEVICE
    • 5.2.4. ORAL APPLIANCES
    • 5.2.5. OXYGEN DEVICES
    • 5.2.6. OTHER THERAPEUTIC

6. MARKET BY END-USER

  • 6.1. HOSPITALS & SLEEP LABORATORIES
  • 6.2. HOME CARE SETTINGS

7. KEY ANALYTICS

  • 7.1. PORTER'S FIVE FORCES MODEL
    • 7.1.1. THREAT OF NEW ENTRANTS
    • 7.1.2. THREAT OF SUBSTITUTE
    • 7.1.3. BARGAINING POWER OF BUYERS
    • 7.1.4. BARGAINING POWER OF SUPPLIERS
    • 7.1.5. THREAT OF COMPETITIVE RIVALRY
  • 7.2. REGULATORY FRAMEWORK
  • 7.3. PETL ANALYSIS
  • 7.4. MARKET TRENDS
  • 7.5. OPPORTUNITY MATRIX

8. GEOGRAPHICAL ANALYSIS

  • 8.1. NORTH AMERICA
    • 8.1.1. THE UNITED STATES
    • 8.1.2. CANADA
  • 8.2. EUROPE
    • 8.2.1. GERMANY
    • 8.2.2. FRANCE
    • 8.2.3. THE UNITED KINGDOM
    • 8.2.4. ITALY
    • 8.2.5. SPAIN
    • 8.2.6. REST OF EUROPE
  • 8.3. ASIA PACIFIC
    • 8.3.1. JAPAN
    • 8.3.2. CHINA
    • 8.3.3. AUSTRALIA
    • 8.3.4. INDIA
    • 8.3.5. SOUTH KOREA
    • 8.3.6. REST OF ASIA PACIFIC
  • 8.4. REST OF THE WORLD
    • 8.4.1. LATIN AMERICA
    • 8.4.2. MIDDLE EAST AND AFRICA

9. COMPETITIVE LANDSCAPE

  • 9.1. MARKET POSITION ANALYSIS
  • 9.2. COMPANY PROFILES
    • 9.2.1. BRAEBON MEDICAL CORPORATION
    • 9.2.2. CADWELL
    • 9.2.3. CAREFUSION (MERGED WITH BECTON DICKINSON)
    • 9.2.4. DRIVE DEVILBISS HEALTHCARE
    • 9.2.5. FISHER & PAYKEL HEALTHCARE
    • 9.2.6. GE HEALTHCARE
    • 9.2.7. INVACARE CORP.
    • 9.2.8. ITAMAR MEDICAL LTD.
    • 9.2.9. KONINKLIJKE PHILIPS N.V. (PHILIPS)
    • 9.2.10. MEDTRONIC PLC
    • 9.2.11. NIHON KOHDEN CORPORATION
    • 9.2.12. RESMED INC.
    • 9.2.13. SMITHS GROUP PLC (SMITHS MEDICAL)
    • 9.2.14. SOMNOMEDICS
    • 9.2.15. TELEFLEX

TABLE LIST

  • TABLE 1 GLOBAL SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 2 PREVALENCE OF SLEEP APNEA BY REGION 2015
  • TABLE 3 PREVALENCE OF COPD BY REGION
  • TABLE 4 GLOBAL SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
  • TABLE 5 GLOBAL SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET BY DIAGNOSTIC DEVICE 2019-2027 ($ MILLION)
  • TABLE 6 GLOBAL POLYSOMNOGRAPHY DEVICE (PSG) MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 7 GLOBAL POLYSOMNOGRAPHY DEVICE (PSG) MARKET BY TYPE 2019-2027 ($ MILLION)
  • TABLE 8 GLOBAL SLEEP APNEA SCREENING DEVICE MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 9 GLOBAL ACTIGRAPHY MONITORING DEVICE MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 10 GLOBAL RESPIRATORY POLYGRAPH MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 11 GLOBAL OXIMETER MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 12 GLOBAL OXIMETER MARKET BY TYPE 2019-2027 ($ MILLION)
  • TABLE 13 GLOBAL SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET BY THERAPEUTIC DEVICE 2019-2027 ($ MILLION)
  • TABLE 14 GLOBAL AIRWAY CLEARANCE SYSTEMS MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 15 GLOBAL ADAPTIVE SERVO-VENTILATION SYSTEMS MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 16 GLOBAL POSITIVE AIRWAY PRESSURE (PAP) DEVICE MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 17 GLOBAL ORAL APPLIANCES MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 18 GLOBAL OXYGEN DEVICES MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 19 GLOBAL OTHER THERAPEUTIC MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 20 GLOBAL SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET BY END-USER 2019-2027 ($ MILLION)
  • TABLE 21 GLOBAL HOSPITALS & SLEEP LABORATORIES MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 22 GLOBAL HOME CARE SETTINGS MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 23 GLOBAL SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET BY REGION 2019-2027 ($ MILLION)
  • TABLE 24 NORTH AMERICA SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET BY COUNTRY 2019-2027 ($ MILLION)
  • TABLE 25 THE UNITED STATES SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
  • TABLE 26 THE UNITED STATES SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET BY END-USER 2019-2027 ($ MILLION)
  • TABLE 27 CANADA SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
  • TABLE 28 CANADA SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET BY END-USER 2019-2027 ($ MILLION)
  • TABLE 29 EUROPE SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET BY COUNTRY 2019-2027 ($ MILLION)
  • TABLE 30 GERMANY SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
  • TABLE 31 GERMANY SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET BY END-USER 2019-2027 ($ MILLION)
  • TABLE 32 FRANCE SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
  • TABLE 33 FRANCE SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET BY END-USER 2019-2027 ($ MILLION)
  • TABLE 34 THE UNITED KINGDOM SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
  • TABLE 35 THE UNITED KINGDOM SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET BY END-USER 2019-2027 ($ MILLION)
  • TABLE 36 ITALY SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
  • TABLE 37 ITALY SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET BY END-USER 2019-2027 ($ MILLION)
  • TABLE 38 SPAIN SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
  • TABLE 39 SPAIN SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET BY END-USER 2019-2027 ($ MILLION)
  • TABLE 40 ASIA PACIFIC SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET BY COUNTRY 2019-2027 ($ MILLION)
  • TABLE 41 JAPAN SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
  • TABLE 42 JAPAN SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET BY END-USER 2019-2027 ($ MILLION)
  • TABLE 43 CHINA SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
  • TABLE 44 CHINA SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET BY END-USER 2019-2027 ($ MILLION)
  • TABLE 45 INDIA SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
  • TABLE 46 INDIA SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET BY END-USER 2019-2027 ($ MILLION)
  • TABLE 47 SOUTH KOREA SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
  • TABLE 48 SOUTH KOREA SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET BY END-USER 2019-2027 ($ MILLION)
  • TABLE 49 REST OF THE WORLD SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET BY COUNTRY 2019-2027 ($ MILLION)
  • TABLE 50 SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC COMPANY MARKET POSITION ANALYSIS 2017
  • FIGURES LIST
  • FIGURE 1 GLOBAL SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
  • FIGURE 2 GLOBAL SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET SHARE 2018 & 2027 (%)
  • FIGURE 3 GLOBAL SLEEP APNEA DIAGNOSTIC MARKET BY POLYSOMNOGRAPHY DEVICE (PSG) 2019-2027 ($ MILLION)
  • FIGURE 4 GLOBAL POLYSOMNOGRAPHY DEVICE (PSG) MARKET BY CLINICAL PSG DEVICE 2019-2027 ($ MILLION)
  • FIGURE 5 GLOBAL POLYSOMNOGRAPHY DEVICE (PSG) MARKET BY AMBULATORY PSG DEVICE 2019-2027 ($ MILLION)
  • FIGURE 6 GLOBAL SLEEP APNEA DIAGNOSTIC MARKET BY SLEEP APNEA SCREENING DEVICE 2019-2027 ($ MILLION)
  • FIGURE 7 GLOBAL SLEEP APNEA DIAGNOSTIC MARKET BY ACTIGRAPHY MONITORING DEVICE 2019-2027 ($ MILLION)
  • FIGURE 8 GLOBAL SLEEP APNEA DIAGNOSTIC MARKET BY RESPIRATORY POLYGRAPH 2019-2027 ($ MILLION)
  • FIGURE 9 GLOBAL SLEEP APNEA DIAGNOSTIC MARKET BY OXIMETER 2019-2027 ($ MILLION)
  • FIGURE 10 GLOBAL OXIMETER MARKET BY FINGER TIP OXIMETER 2019-2027 ($ MILLION)
  • FIGURE 11 GLOBAL OXIMETER MARKET BY HANDHELD OXIMETER 2019-2027 ($ MILLION)
  • FIGURE 12 GLOBAL OXIMETER MARKET BY WRIST-WORN OXIMETER 2019-2027 ($ MILLION)
  • FIGURE 13 GLOBAL OXIMETER MARKET BY TABLETOP OXIMETER 2019-2027 ($ MILLION)
  • FIGURE 14 GLOBAL SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET SHARE BY THERAPEUTIC 2018 & 2027 (%)
  • FIGURE 15 GLOBAL SLEEP APNEA THERAPEUTIC MARKET BY AIRWAY CLEARANCE SYSTEMS 2019-2027 ($ MILLION)
  • FIGURE 16 GLOBAL SLEEP APNEA THERAPEUTIC MARKET BY ADAPTIVE SERVO -VENTILATION SYSTEMS 2019-2027 ($ MILLION)
  • FIGURE 17 GLOBAL SLEEP APNEA THERAPEUTIC MARKET BY POSITIVE AIRWAY PRESSURE (PAP) DEVICE 2019-2027 ($ MILLION)
  • FIGURE 18 GLOBAL SLEEP APNEA THERAPEUTIC MARKET BY ORAL APPLIANCES 2019-2027 ($ MILLION)
  • FIGURE 19 GLOBAL SLEEP APNEA THERAPEUTIC MARKET BY OXYGEN DEVICES 2019-2027 ($ MILLION)
  • FIGURE 20 GLOBAL SLEEP APNEA THERAPEUTIC MARKET BY OTHER THERAPEUTIC 2019-2027 ($ MILLION)
  • FIGURE 21 GLOBAL SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET SHARE BY END-USER 2018 & 2027 (%)
  • FIGURE 22 GLOBAL SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET BY HOSPITALS & SLEEP LABORATORIES 2019-2027 ($ MILLION)
  • FIGURE 23 GLOBAL SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET BY HOME CARE SETTINGS 2019-2027 ($ MILLION)
  • FIGURE 24 PORTER'S FIVE FORCE MODEL
  • FIGURE 25 GLOBAL SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET REGIONAL OUTLOOK 2018 & 2027 (%)
  • FIGURE 26 THE UNITED STATES SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
  • FIGURE 27 CANADA SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
  • FIGURE 28 GERMANY SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
  • FIGURE 29 FRANCE SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
  • FIGURE 30 THE UNITED KINGDOM SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
  • FIGURE 31 ITALY SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
  • FIGURE 32 SPAIN SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
  • FIGURE 33 REST OF EUROPE SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
  • FIGURE 34 JAPAN SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
  • FIGURE 35 CHINA SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
  • FIGURE 36 AUSTRALIA SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
  • FIGURE 37 AUSTRALIA SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
  • FIGURE 38 AUSTRALIA SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET BY END-USER 2019-2027 ($ MILLION)
  • FIGURE 39 INDIA SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
  • FIGURE 40 SOUTH KOREA SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
  • FIGURE 41 REST OF ASIA PACIFIC SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
  • FIGURE 42 LATIN AMERICA SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
  • FIGURE 43 MIDDLE EAST AND AFRICA SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
Back to Top